ES471672A1 - Un procedimiento para la preparacion de un peptido - Google Patents

Un procedimiento para la preparacion de un peptido

Info

Publication number
ES471672A1
ES471672A1 ES471672A ES471672A ES471672A1 ES 471672 A1 ES471672 A1 ES 471672A1 ES 471672 A ES471672 A ES 471672A ES 471672 A ES471672 A ES 471672A ES 471672 A1 ES471672 A1 ES 471672A1
Authority
ES
Spain
Prior art keywords
group
hydroxy
formula
treatment
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES471672A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of ES471672A1 publication Critical patent/ES471672A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se describen nuevos péptidos de fórmula: **(Fórmula)** (junto con composiciones farmacéuticas efectiva de los mismos), donde X1 y X2 representan un grupo hidroxi o amino y B representa: (1) hidroxi o (2) un resto de un aminoácido seleccionado entre el grupo formado por L-Asp-OH, L-Asn-OH, L-Glu-OH, L-Gln-OH, L-Ser-OH o HN-A-COOH, donde A es un grupo alquilideno de 1 a 6 átomos de carbono; o un derivado funcional de los mismos. Estos péptidos presentan propiedades psicofarmacológicas; son adecuados para el tratamiento de ciertos trastornos mentales en los que se desea estimular la función cerebral, v.g. para el tratamiento de la senibilidad y/o de la amnesia.
ES471672A 1977-07-13 1978-07-12 Un procedimiento para la preparacion de un peptido Expired ES471672A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7707781A NL7707781A (nl) 1977-07-13 1977-07-13 Psychofarmacologische peptiden.

Publications (1)

Publication Number Publication Date
ES471672A1 true ES471672A1 (es) 1979-09-16

Family

ID=19828866

Family Applications (1)

Application Number Title Priority Date Filing Date
ES471672A Expired ES471672A1 (es) 1977-07-13 1978-07-12 Un procedimiento para la preparacion de un peptido

Country Status (16)

Country Link
US (1) US4203975A (es)
JP (1) JPS5419934A (es)
AU (1) AU519567B2 (es)
BE (1) BE868953A (es)
CA (1) CA1108123A (es)
DE (1) DE2830489A1 (es)
DK (1) DK149454C (es)
ES (1) ES471672A1 (es)
FI (1) FI67367C (es)
FR (1) FR2397395A1 (es)
GB (1) GB2001076B (es)
IE (1) IE47547B1 (es)
LU (1) LU79960A1 (es)
NL (1) NL7707781A (es)
SE (1) SE443789B (es)
ZA (1) ZA783713B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU530062B2 (en) * 1979-02-21 1983-06-30 Akzo N.V. Psycho-pharmacological peptides
JPH0195597U (es) * 1987-12-17 1989-06-23
US5796673A (en) 1994-10-06 1998-08-18 Mosaid Technologies Incorporated Delay locked loop implementation in a synchronous dynamic random access memory
US9908972B2 (en) * 2013-05-22 2018-03-06 National Institute Of Advanced Industrial Science And Technology Photodegradable cross-linking agent, photodegradable gel, cell culture instrument, cell arrangement-sorting apparatus, cell arrangement method, cell sorting method, tissue forming method, and tissue
BR112015032713B1 (pt) * 2013-09-17 2023-03-21 Obi Pharma, Inc Composto, composição farmacêutica, uso de uma quantidade terapeuticamente efetiva da composição farmacêutica, e uso do composto
US10980894B2 (en) 2016-03-29 2021-04-20 Obi Pharma, Inc. Antibodies, pharmaceutical compositions and methods
KR20250048399A (ko) 2016-04-22 2025-04-08 오비아이 파머 인코퍼레이티드 글로보 계열 항원을 통한 면역 활성화 또는 면역 조정에 의한 암 면역요법
US11642400B2 (en) 2016-07-27 2023-05-09 Obi Pharma, Inc. Immunogenic/therapeutic glycan compositions and uses thereof
JP7121724B2 (ja) 2016-07-29 2022-08-18 オービーアイ ファーマ，インコーポレイテッド ヒト抗体、医薬組成物及び方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803119A (en) * 1970-04-20 1974-04-09 Daiichi Seiyaku Co Pantetheine-s-sulfonic acid derivatives and salts thereof
NL175293C (nl) * 1972-02-08 1984-10-16 Akzo Nv Werkwijze ter bereiding of vervaardiging van een farmaceutisch preparaat met psychofarmacologische werking, alsmede werkwijze voor het bereiden van een van vasopressine afgeleid peptide.

Also Published As

Publication number Publication date
CA1108123A (en) 1981-09-01
IE47547B1 (en) 1984-04-18
DE2830489A1 (de) 1979-01-25
BE868953A (fr) 1979-01-12
DK314978A (da) 1979-01-14
JPS6220200B2 (es) 1987-05-06
FI67367B (fi) 1984-11-30
FR2397395B1 (es) 1981-01-16
IE781291L (en) 1979-01-13
FR2397395A1 (fr) 1979-02-09
AU3778078A (en) 1980-01-10
JPS5419934A (en) 1979-02-15
DK149454B (da) 1986-06-16
DK149454C (da) 1986-11-17
AU519567B2 (en) 1981-12-10
FI67367C (fi) 1985-03-11
GB2001076B (en) 1982-01-27
LU79960A1 (fr) 1979-04-09
US4203975A (en) 1980-05-20
GB2001076A (en) 1979-01-24
NL7707781A (nl) 1979-01-16
FI782195A7 (fi) 1979-01-14
ZA783713B (en) 1979-07-25
SE443789B (sv) 1986-03-10
SE7807759L (sv) 1979-01-14

Similar Documents

Publication Publication Date Title
ES2039278T3 (es) Procedimiento para preparar inhibidores de 5-alfa-reductasa de esteroides.
ES2038613T3 (es) Procedimiento para preparar derivados de 4,5,6,7-tetrahidro-1h-imidazo(4,5-c)piridina y analogos de los mismos que tienen actividad antihipertensiva.
GT199800046A (es) Compuestos de pirazina.
ES2013067A6 (es) Un procedimiento para producir un derivado de piperazina.
ES2080764T3 (es) Derivados de acidos biliares fluorados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
ES2009723T3 (es) Derivados de acidos biliares, procedimientos para la preparacion de los mismos y composiciones farmaceuticas conteniendolos.
ES2052166T3 (es) Derivados de 24-homo-vitamina-d, procedimiento para su preparacion, preparados farmaceuticos que contienen estos derivados asi como su utilizacion como medicamentos.
ES2074492T3 (es) Derivados de acidos biliares, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
KR870700599A (ko) 카르복실산유도체, 그의 제조방법, 이화합물을 함유한 약제조성물 및 그의 용도
ES471672A1 (es) Un procedimiento para la preparacion de un peptido
SE7608092L (sv) Nya steroider
ES2188743T3 (es) Compuestos de acido pirrolidinilhidroxamico y procedimiento de produccion de los mismos.
ES496038A0 (es) Procedimiento para la obtencion de 2-hidroxialquil-3,4,5- trihidroxi-piperidinas
PT81345B (pt) Processo para a preparacao de novos peptideos activos sobre o sistema nervoso central com accao sobre o sistema colinergico, e de composicoes farmaceuticas contendo estes compostos
ZA886097B (en) Pharmaceutical composition for the treatment of psoriasis
ES2102043T3 (es) Derivados de 22-en-25-oxa en la serie de la vitamina d, procedimiento para su preparacion, preparados farmaceuticos que los contienen, asi como su utilizacion en calidad de medicamentos.
DK0417003T3 (da) Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation
FR2379549A1 (fr) 4''-deoxy-4''-(amino substitue)-oleandomycines et medicament les contenant
ATE114468T1 (de) Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs.
ATE13423T1 (de) Guanidinderivate und diese enthaltende pharmazeutische zusammensetzungen.
ES447732A1 (es) Procedimiento para la preparacion de autraquinon-bis-amidi- nas.
FI904475A7 (fi) Tymopentiiniä sisältävät koostumukset ihosairauksien hoitamiseksi paik allisesti
DE69822937D1 (de) Indolmorphinan-derivate und medikamente zur behandlung/mittel zur vorbeugung von cerebralen störungen
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
ES2036545T3 (es) Derivados de n-1h-tetrazol-5-il-(anillo de 5 eslabones)-carboxamida, un procedimiento para su preparacion y el uso de los mismos.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980202